The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gabapentin 100 mg Capsules, Hard

100 milligram(s) Capsule

McDermott Laboratories Ltd t/a Gerard LaboratoriesPA0577/097/001

Main Information

Trade NameGabapentin 100 mg Capsules, Hard
Active SubstancesGabapentin
Strength100 milligram(s)
Dosage FormCapsule
Licence HolderMcDermott Laboratories Ltd t/a Gerard Laboratories
Licence NumberPA0577/097/001

Group Information

ATC CodeN03AX Other antiepileptics
N03AX12 gabapentin

Status

Authorised/WithdrawnAuthorised
Licence Issued18/11/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back